USPTO serial 79343304
HISTOCYTE LABORATORIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 23, 2024
- Examiner
- BLAKESLEE, RICHARD A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HISTOCYTE LABORATORIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mari-Elise Paul
Mari-Elise Paul McBrayer PLLC500 West Jefferson Street, Suite 2400LOUISVILLE, KY 40202United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; diagnostic preparations for scientific or research use; chemical preparations for scientific purposes, other than for medical or veterinary use; reagents for scientific purposes; reagents for medical research; reagents for research purposes; diagnostic reagents for scientific or research use; biochemical reagents used for non-medical purposes; diagnostic reagents for in-vitro use other than medical or veterinary purposes; reagents for laboratory purposes other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; reagents for analytical purposes other than for medical or veterinary purposes; reagents for in-vitro laboratory use other than for medical or veterinary purposes; reagents for use in diagnostic tests other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical products for diagnostic and scientific use, namely, immunohistochemistry ("IHC") cell line controls for slide control of samples and tissue samples; chemical products for scientific use other than medical or veterinary purposes; chemical substances for analysis in laboratories, other than for medical or veterinary purposes; chemicals for use in analysis other than medical and veterinary purposes; chemicals for use in scientific analysis other than medical and veterinary purposes; diagnostic preparations for scientific purposes; diagnostic testing materials, other than for medical use; diagnostic chemicals other than for medical or veterinary use | ACTIVE | — |
| 005 | Medical diagnostic reagents; clinical diagnostic reagents for medical use; reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; diagnostic reagents for medicinal use; chemical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for use in diagnostic tests for medical purposes; reagents and media for medical and veterinary diagnostic purposes; medical diagnostic reagents and assays for testing of body fluids; biological tissue cultures for medical purposes; diagnostic agents for medical use; in vitro diagnostic preparations for medical use; pharmaceutical preparations in the nature of quality control preparations for use in connection with immunohistochemistry and in situ hybridisation assays | ACTIVE | — |
| 042 | Biochemistry research services; cell culture services for scientific and research purposes, for others; cell separation research services; research and development in the pharmaceutical and biotechnology fields; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the field of diagnostic preparations; scientific and technological design services, namely, development of tissue diagnostic assays for running clinical trial assays for the analysis of cancer biomarkers in the field of cancer research and diagnosis; scientific and technological services, namely, development of tissue diagnostic assays for running clinical trial assays for the analysis of cancer biomarkers in the field of cancer research and diagnosis; consultancy in the field of biotechnology; industrial analysis and research in the field of cancer research and diagnosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HistoCyte Laboratories Ltd
- Other trademarks owned by HistoCyte Laboratories Ltd
- Other trademarks owned by HistoCyte Laboratories Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named HISTOCYTE LABORATORIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 23, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 23, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 24, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 10, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 6, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 6, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 17, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 3, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 18, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 2, 2023 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Oct 2, 2023 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Oct 2, 2023 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Sep 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 23, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 23, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 23, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 25, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 25, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 17, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 24, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 23, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |